The Genomic Atlas of Breast Cancer — the non-coding theme

Update News

  • GABC update 2020.06.15
  • GABC update 2019.03.20
  • GABC online 2018.08.09
  • Data collection 2018.04.09

About Us

  • Steven Xi Chen:
    steven.chen@miami.edu
  • Yunpeng Zhang:
    YXZ1418@med.miami.edu
  • Peng Wang:
    wpgqy@163.com
  • Shangwei Ning:
    ningsw@ems.hrbmu.edu.cn
  • Xia Li:
    lixia@hrbmu.edu.cn

Detail


Chr chr19
start 13836440
end 13836517
ID MI0000085
miRNA_name hsa-miR-27a
methods qRT-PCR,etc.
regulated up
Function Description Results:Both expression and mean rank of miR 27a and tumor markers among BC patients as com-pared to the other two groups. Clinicopathological characteristics showed significant relation withmiRN 27a expression for clinical stage, histological grading, ER receptor and HER-2/neu. The diagnosticefficacy for miR 27a was superior to both tumor markers for early detection of BC especially high-riskBC groups.Conclusion:Detection of miR 27a expression may serve as a potential sensitive minimally invasivemolecular marker for early detection of primary BC.
PMID 31145011
year 2019
Title Serum MiRNA-27a as Potential Diagnostic Nucleic Marker for Breast Cancer
drug X
circulating V
survival X

CopyRight © University of Miami, USA; Harbin Medical University, China